Achillion to Present at the JMP Securities Life Sciences Conference

NEXT STORY
G1 Therapeutics Announces Updates to Board of Directors
PREV STORY
First Patient Dosed with Gevokizumab in Collaborator Clinical Study in Metastatic Colorectal Cancer, Gastroesophageal Cancer, and Renal Cell Carcinoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Soricimed Publishes New Research Validating TRPV6 as a Therapeutic Target for Ovarian Cancer

MONCTON, New Brunswick, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a ...

author_avatar
NASDAQ Market News

Stemline Therapeutics Closes $92 Million Public Offering of Common Stock

NEW YORK, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a ...

author_avatar
NASDAQ Market News

Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results

MEDFORD, N.Y., March 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

author_avatar
NASDAQ Market News